Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1965;31:670-678

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORRIS, J. J.
Right arrow Articles by MCINTOSH, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORRIS, J. J., JR.
Right arrow Articles by MCINTOSH, H.

(Circulation. 1965;31:670.)
© 1965 American Heart Association, Inc.


The Changes in Cardiac Output with Reversion of Atrial Fibrillation to Sinus Rhythm

JAMES J. MORRIS JR. M.D.1; MARK ENTMAN M.D.1; WILLIAM C. NORTH M.D.1; YIHONG KONG M.D.1; HENRY MCINTOSH M.D.1

1 From the Cardiovascular Laboratory, Department of Medicine and the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.

Twelve patients were reverted from atrial fibrillation to sinus rhythm by the technic of "cardioversion." Brief, light anesthesia was the only drug employed. Under conditions of comparable oxygen consumption cardiac output was measured first in atrial fibrillation and then in sinus rhythm. Eleven patients were studied at rest and five during exercise.

Ten of the 11 patients studied at rest showed a reduced arteriovenous oxygen difference with sinus rhythm and seven of the 11 increased cardiac output 0.6 L./min. or greater, an average increase of 34 per cent. All five patients studied at exercise decreased the arteriovenous oxygen difference with sinus rhythm and cardiac output rose 1.1 L./min. or greater in all, an average increase of 17 per cent.




This article has been cited by other articles:


Home page
Eur Heart JHome page
F. T. Range, M. Schafers, T. Acil, K. P. Schafers, P. Kies, M. Paul, S. Hermann, B. Brisse, G. Breithardt, O. Schober, et al.
Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation
Eur. Heart J., September 2, 2007; 28(18): 2223 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.-C. Tardif and M. Talajic
Perindopril and prevention of atrial fibrillation
Eur. Heart J. Suppl., September 1, 2007; 9(suppl_E): E25 - E29.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Roy, M. Talajic, P. Dorian, S. Connolly, M. J. Eisenberg, M. Green, T. Kus, J. Lambert, M. Dubuc, P. Gagne, et al.
Amiodarone to Prevent Recurrence of Atrial Fibrillation
N. Engl. J. Med., March 30, 2000; 342(13): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone
Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience
Europace, January 1, 2000; 2(2): 119 - 126.
[Abstract] [PDF]


Home page
NEJMHome page
W. J. Manning, D. I. Silverman, S. Gordon, H. M. Krumholz, and P. S. Douglas
Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi
N. Engl. J. Med., March 18, 1993; 328(11): 750 - 755.
[Abstract] [Full Text]